Great thread, it gets to to the heart of what this company is about. The (perhaps small) possibility of a paradigm change in the treatment of cancer.
It is not about charts channeling between 2c - 2.4 cents. Of course there is accumulation, of course some are taking advantage of a news hiatus. What did the charts say about the forays from high 2's to 4 and then back again. Then the 2.7c cap raise and the subsequent pull back to where we are now. They told us ABSOLUTELY zilch.
This company is not about charts, it is about cancer and if there is any big money to be made or significant capital to be lost it will be due to the fundamentals. Traders will simply be lucky or unlucky, dependent on news, to be in or out at the times of inflection point drama WHEN they occur.
IMU Price at posting:
2.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)